HMS Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.99M Sell
1,657
-33
-2% -$33.7K 0.74% 30
2026
Q1
$1.55M Sell
1,690
-97
-5% -$98.3K 0.6% 36
2025
Q4
$1.92M Sell
1,787
-26
-1% -$24.9K 0.79% 31
2025
Q3
$1.38M Buy
1,813
+195
+12% +$145K 0.58% 41
2025
Q2
$1.26M Sell
1,618
-115
-7% -$89.4K 0.57% 41
2025
Q1
$1.25M Buy
+1,733
New +$1.44M 0.7% 43

Other funds holding LLY

HMS Capital Management's LLY Position: Q2 2026 in Review

HMS Capital Management reduced its Eli Lilly (LLY) stake by 2% in Q2 2026, selling an estimated $33.7K and leaving 1,657 shares worth $1.99M. The position accounts for 0.74% of the portfolio, ranked #30.

HMS Capital Management first reported a position in LLY in Q1 2025 and has held it in 6 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • HMS Capital Management held 1,657 shares of Eli Lilly worth $1.99M as of Q2 2026.
  • HMS Capital Management sold 33 Eli Lilly shares in Q2 2026, an estimated $33.7K.
  • Eli Lilly made up 0.74% of HMS Capital Management's portfolio in Q2 2026, its #30 holding.
  • HMS Capital Management first reported a position in Eli Lilly in Q1 2025 and has held it in 6 quarters since.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on HMS Capital Management's 13F filing for Q2 2026, filed 21 Jul 2026.